Experience of Patients Treated with Sipuleucel-T in an Academic Setting

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Optimizing the efficiency and quality of sipuleucel-T delivery in an academic institution.

BACKGROUND Sipuleucel-T, an autologous cellular immunotherapy, is approved for the treatment of certain patients with metastatic castration-resistant prostate cancer (mCRPC). Sipuleucel-T is the first personalized treatment for prostate cancer to be manufactured using the immune system of each individual patient. Patient preparation and compliance are critical because patients undergo serial le...

متن کامل

Sipuleucel-T (Provenge) Injection

INTRODUCTION Among the leading causes of cancerrelated deaths, prostate cancer is second to lung cancer, but it is the most frequently occurring noncutaneous cancer among men in the U.S.1 Therapies for prostate cancer depend on age, rate of the cancer’s growth, the specific benefits and drawbacks of treatment, and stage of disease. Patients older than 70 years of age with a slowly growing, loca...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Annals of Oncology

سال: 2014

ISSN: 0923-7534

DOI: 10.1093/annonc/mdu342.25